» Articles » PMID: 33447787

10-Year Community Prevalence and Trends of Severe Asymptomatic Hypertension Among Patients with Hypertension in the USA: 2007-2016

Overview
Date 2021 Jan 15
PMID 33447787
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Severe asymptomatic hypertension (SAH) is associated with significant health cost, morbidity and mortality.

Aim: Establish the nationwide prevalence, trends and associated sociodemographic characteristics of SAH among patients with hypertension in the USA.

Methods: We utilized the National Health and Nutrition Examination data collected over five survey cycles (2007-2016). Included were participants aged 20-80 years with self-reported diagnosis of hypertension. SAH was defined as having a mean systolic blood pressure (SBP) ≥180 mmHg and/or mean diastolic blood pressure (DBP) ≥120 mmHg at the time of examination. The Chi square test was used to compare prevalence across different categories. Associations between sociodemographic variables and SAH were assessed using multivariate binary logistic regression.

Results: The prevalence of SAH among patients with hypertension is 2.15% (95% CI 1.80-2.56), mainly explained by isolated mean SBP≥180 mmHg (86% of all cases), with no statistically significant change between 2007: 2.66% (95% CI 2.10-3.36) and 2016:2.61% [95% CI 1.73-3.94), p-trend = 0.17. Increasing age (OR 1.07, 95% CI 1.04-1.09), NH Blacks (OR 2.20, 95% CI 1.37-3.54), BMI< 25 (OR 2.52, 95% CI 1.48-4.28), lack of health insurance OR 4.92% (95% CI 2.53-9.54) and never married individuals (OR = 2.59%, 95% CI 1.20-5.60) were more likely to have SAH, comparatively. There was no significant association between duration of hypertension and SAH.

Conclusion: The prevalence of SAH in the USA is 2.15% and has been stable over the past decade. Our study underscores the importance of identifying barriers to screening and treatment of hypertension which is a major treatable risk factor for cardiovascular disease.

Citing Articles

Clinical utility of routine investigations and risk factors of end-organ damage in asymptomatic severe hypertension.

Ali N, Aftab U, Soomar S, Tareen H, Khan U, Khan B Intern Emerg Med. 2023; 18(7):2037-2043.

PMID: 37668749 DOI: 10.1007/s11739-023-03403-8.


Can anthropometric indices predict the chance of hypertension? A multicentre cross-sectional study in Iran.

Akbari-Khezrabadi A, Zibaeenezhad M, Shojaeefard E, Naseri A, Mousavi S, Sarejloo S BMJ Open. 2022; 12(11):e062328.

PMID: 36418117 PMC: 9685002. DOI: 10.1136/bmjopen-2022-062328.

References
1.
Bender S, Fong M, Heitz S, Bisognano J . Characteristics and management of patients presenting to the emergency department with hypertensive urgency. J Clin Hypertens (Greenwich). 2006; 8(1):12-8. PMC: 8109533. DOI: 10.1111/j.1524-6175.2005.04898.x. View

2.
Kramer B, Kramer R, Benck U, Kruger B . Nonadherence in patients with hypertensive emergency or hypertensive urgency. J Clin Hypertens (Greenwich). 2018; 21(1):64-66. PMC: 8030474. DOI: 10.1111/jch.13442. View

3.
Bennett N, Shea S . Hypertensive emergency: case criteria, sociodemographic profile, and previous care of 100 cases. Am J Public Health. 1988; 78(6):636-40. PMC: 1350272. DOI: 10.2105/ajph.78.6.636. View

4.
Egan B, Zhao Y, Axon R . US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010; 303(20):2043-50. DOI: 10.1001/jama.2010.650. View

5.
Whelton P, Carey R, Aronow W, Casey Jr D, Collins K, Himmelfarb C . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on.... Hypertension. 2017; 71(6):e13-e115. DOI: 10.1161/HYP.0000000000000065. View